Atenolol and Abiraterone acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atenolol (atenolol) and Abiraterone acetate (abiraterone acetate). Common drug interactions include agitation among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Atenolol and Abiraterone acetate. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 176,618 Atenolol users. Check the latest studies of Atenolol.

What is Abiraterone acetate?

Abiraterone acetate has active ingredients of abiraterone acetate. eHealthMe is studying from 6,297 Abiraterone acetate users. Check the latest studies of Abiraterone acetate.



On Jul, 07, 2026

88 people who take Atenolol and Abiraterone acetate together, and have interactions are studied.

Atenolol and Abiraterone acetate drug interactions.

What are the common drug interactions of Atenolol and Abiraterone Acetate, by gender? *:

female:

  1. Agitation (state of anxiety or nervous excitement)
  2. Abnormal behaviour
  3. Completed suicide (act of taking one's own life)
  4. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Hypotension (abnormally low blood pressure)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

male:

  1. Abdominal pain upper
  2. Abdominal pain
  3. Dyspepsia (indigestion)
  4. Flatulence (flatus expelled through the anus)
  5. Headache (pain in head)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Lower respiratory tract infection
  8. Fatigue (feeling of tiredness)
  9. Alanine aminotransferase increased
  10. Cardiac failure congestive

What are the common drug interactions of Atenolol and Abiraterone Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Septic shock (shock due to blood infection)
  2. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  3. Abdominal pain upper
  4. Disturbance in attention
  5. Educational problem

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Dyspepsia (indigestion)
  4. Flatulence (flatus expelled through the anus)
  5. Headache (pain in head)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Hypokalaemia (low potassium)
  8. Lower respiratory tract infection
  9. Urinary tract infection
  10. Alanine aminotransferase increased

What are the existing conditions these people have? *

  1. Prostate Cancer Metastatic: 41 people, 46.59%
  2. Prostate Cancer: 37 people, 42.05%
  3. Type 2 Diabetes: 11 people, 12.50%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 11 people, 12.50%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 11.36%
  6. High Blood Cholesterol: 9 people, 10.23%
  7. Back Pain: 7 people, 7.95%
  8. Pain: 6 people, 6.82%
  9. Osteoporosis (bones weak and more likely to break): 5 people, 5.68%
  10. Neuralgia (pain in one or more nerves): 5 people, 5.68%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and Abiraterone acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atenolol and Abiraterone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abiraterone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atenolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abiraterone acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atenolol and abiraterone acetate (the active ingredients of Atenolol and Abiraterone acetate, respectively), and Atenolol and Abiraterone acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: